Issued Patents All Time
Showing 1–25 of 36 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11746103 | ALK-5 inhibitors and uses thereof | Bettina Franz, Adam Siddiqui-Jain, Siva Reddy Basireddy, Srinivas Padakanti, Naresh Kumar | 2023-09-05 |
| 11712433 | Compositions comprising PKM2 modulators and methods of treatment using the same | David J. Bearss, Jason Marc Foulks | 2023-08-01 |
| 11529350 | Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof | Adam Siddiqui-Jain, Jeyaprakashnarayanan Seenisamy, Clifford J. Whatcott, David J. Bearss | 2022-12-20 |
| 11497756 | Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott | 2022-11-15 |
| 11471456 | Formulations comprising heterocyclic protein kinase inhibitors | Adam Siddiqui-Jain, Paul Flynn | 2022-10-18 |
| 11400091 | AXL kinase inhibitors and use of the same | Adam Siddiqui-Jain, Paul Flynn, David J. Bearss, Jason Marc Foulks, Nozomi Tomimatsu +4 more | 2022-08-02 |
| 11040038 | Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Jason Marc Foulks, Stephen Patrick Anthony +3 more | 2021-06-22 |
| 10835537 | Combination therapies for treatment of cancer | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Wontak Kim | 2020-11-17 |
| 10752594 | JAK1 and ALK2 inhibitors and methods for their use | Alexis Henri Abel Mollard, Gary A. Flynn, Hariprasad Vankayalapati, David J. Bearss | 2020-08-25 |
| 10682356 | Combination therapies for treatment of cancer | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Wontak Kim | 2020-06-16 |
| 10624880 | Predicting response to alvocidib by mitochondrial profiling | David J. Bearss | 2020-04-21 |
| 10568887 | Combination therapies for treatment of cancer | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Wontak Kim | 2020-02-25 |
| 10422788 | Profiling peptides and methods for sensitivity profiling | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Lars Mouritsen | 2019-09-24 |
| 10357488 | Predicting response to alvocidib by mitochondrial profiling | David J. Bearss | 2019-07-23 |
| 10267787 | Profiling peptides and methods for sensitivity profiling | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Lars Mouritsen | 2019-04-23 |
| 10202356 | JAK2 and ALK2 inhibitors and methods for their use | Alexis Henri Abel Mollard, Gary A. Flynn, Hariprasad Vankayalapati, David J. Bearss | 2019-02-12 |
| 10132797 | Profiling peptides and methods for sensitivity profiling | David J. Bearss, Adam Siddiqui-Jain, Clifford J. Whatcott, Peter W. Peterson, Lars Mouritsen | 2018-11-20 |
| 9901574 | Predicting response to alvocidib by mitochondrial profiling | David J. Bearss | 2018-02-27 |
| 9828376 | Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors | Hariprasad Vankayalapati, Venkataswamy Sorna, David J. Bearss, Sunil Sharma | 2017-11-28 |
| 9714247 | Multiple kinase pathway inhibitors | Qingping Zeng, Mary Faris, Alexis Henri Abel Mollard, Gary A. Flynn | 2017-07-25 |
| 9642857 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | Hariprasad Vankayalapati, Venkataswamy Sorna, Bret Stephens, David J. Bearss, Sunil Sharma | 2017-05-09 |
| 9555024 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | Hariprasad Vankayalapati, Venkataswamy Sorna, Bret Stephens, David J. Bearss, Sunil Sharma | 2017-01-31 |
| 9493454 | Multiple kinase pathway inhibitors | Qingping Zeng, Mary Faris, Alexis Henri Abel Mollard, Gary A. Flynn | 2016-11-15 |
| 9296703 | Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors | Hariprasad Vankayalapati, Venkataswamy Sorna, David J. Bearss, Sunil Sharma | 2016-03-29 |
| 9266838 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | Hariprasad Vankayalapati, Venkataswamy Sorna, Bret Stephens, David J. Bearss, Sunil Sharma | 2016-02-23 |